By Lee Walpole on
Why it is planned for a future formula.
- Planned for a future Gut+ formula
- Being evaluated for gut comfort
- Will join the powder once it can be made edible and stable
Evidence: Rodent preclinical study. See the science below.
KPV research so far
- KPV is the last three amino acids of alpha-melanocyte-stimulating hormone, a natural hormone involved in inflammation and pigmentation.
- In mice with chemically induced colitis, KPV given by mouth or injection reduced weight loss, gut inflammation and inflammatory markers. A 2008 study also showed KPV enters cells through the PepT1 transporter.
- Later rodent work packaged KPV in nanoparticles or hydrogels to reach the colon. These are laboratory formulations, not products you can buy.
- In May 2026 FDA staff found no pharmacokinetic, toxicity or human studies of KPV by any route and concluded the evidence weighs against adding it to the compounding bulks list. An advisory committee later voted narrowly to recommend it. That vote is non-binding and FDA has not made a final decision.
What is still unknown about KPV
- Whether KPV helps dogs with gut disease, skin inflammation or anything else. Chemically induced colitis in mice is not the same as naturally occurring canine disease.
- Safety. No acute, repeat-dose, reproductive or cancer safety studies have been published in any species, and the exact molecular target is still debated.
- Whether KPV reaches the tissue it is meant to act on. It did not pass easily through human skin in a cell study, and gut studies needed special carriers.
What to ask your vet about KPV
Bring this page and its sources to your veterinarian. Ask whether the research on KPV covered dogs like yours, whether it matches the exact formulation being proposed, and what is known about its safety and legal status. Your veterinarian knows your dog’s history.
Common questions about KPV
No. KPV is not an approved animal drug and is not a component of any FDA-approved human drug. A patent or an online listing is not an approval.
Not that we can find. The published research is in mice, rats and human cell lines, mostly in models of colitis. Those results are a reason for further research, not evidence that KPV is safe or effective in a dog.
Sources
- Kannengiesser et al. (2008): KPV in two mouse models of inflammatory bowel disease Rodent preclinical study
- Dalmasso et al. (2008): PepT1-mediated KPV uptake reduces intestinal inflammation Rodent and cell preclinical study
- Xiao et al. (2017): oral nanoparticle delivery of KPV in a mouse colitis model Rodent preclinical study
- FDA (May 2026): evaluation of KPV for the 503A bulk drug substances list US regulatory evaluation
- FDA: bulk drug substances for compounding that may present significant safety risks US regulatory guidance
Educational information, not veterinary advice. Each sachet is pre-measured; follow the serving guide on the pack and speak with your veterinarian before changing your dog's care.